Hyperbaric oxygen therapy
Hyperbaric oxygen therapy (HBOT) delivers near-pure oxygen in a chamber above normal air pressure. The Undersea and Hyperbaric Medical Society lists accepted hospital indications, including decompression sickness, air or gas embolism and carbon monoxide poisoning. The FDA regulates the chambers as Class II devices. Longevity clinics offer courses of sessions for ageing and cognition, supported by small trials in healthy older adults and no evidence of lifespan benefit. Evidence tier: limited.
What it is
Hyperbaric oxygen therapy (HBOT) means breathing near-pure oxygen inside a sealed chamber pressurized above normal air pressure, which dissolves more oxygen into the blood than breathing air does. In hospitals it treats a defined set of conditions. The Undersea and Hyperbaric Medical Society lists them, and the list includes decompression sickness, air or gas embolism, carbon monoxide poisoning and delayed radiation injury. The chambers are Class II medical devices cleared by the FDA. Longevity clinics sell it differently, as a course of repeated sessions aimed at general ageing, cognition or recovery. That use rests on small studies, including a 60-session protocol tested in healthy adults over 64, and sits outside the conditions hospital medicine treats with it. Fire is the hazard the FDA stresses for pressurized chambers.
Who it is for
The people with an established case for HBOT are patients with a condition on the UHMS indications list, such as decompression sickness among divers, carbon monoxide poisoning or radiation injury to tissue, where it is prescribed and supervised in a hospital. Healthy adults buying a course for ageing or cognition are a different group. The evidence for them comes from small trials in older adults and does not show that the course extends healthy years. Anyone considering a course for longevity should treat it as an unproven use.
What to expect
A session means lying or sitting in a sealed chamber while pressure is raised, breathing oxygen through a mask or hood or from the chamber air, then a controlled return to normal pressure. The FDA tells providers to supervise patients for the full treatment, to follow the manufacturer's list of prohibited items and to ground static-generating items, because oxygen at high concentration raises fire risk. Longevity programs sell courses of repeated sessions. The protocol tested in healthy older adults ran to 60 sessions, which is a long commitment compared with the single-visit packages some clinics sell. Pressure can strain the ears and sinuses.
History and background
The Undersea and Hyperbaric Medical Society keeps the list of conditions hospital HBOT is accepted for. That list has changed over time. The edition read for this entry carries 15 entries and marks idiopathic sudden sensorineural hearing loss as added by the society's board in October 2011. In the United States the chambers are regulated as Class II devices cleared through the FDA's 510(k) pathway. Its use for general ageing is a recent extension, and the telomere and cognition trials in healthy older adults were published in 2020.
Worth knowing
The UHMS list names decompression sickness as one of its accepted uses, alongside air or gas embolism and carbon monoxide poisoning. Healthy ageing is not on it. The FDA's August 2025 letter to providers says it does not know the root cause of the recent chamber fires and that serious adverse events are rare but do occur. Two 2020 trials in Aging reported on telomere length and cognition in older adults, and neither measured lifespan.
Offered across the Atlas 9
Related modalities